Skip to main content

Jordi Riera Heredia

I'm Jordi Riera Heredia, Laboratory technician, currently working in the Neurodegenerative group. I have been a technician since 2008. I have been a technician in different institutions.

Institutions of which they are part

Research technician
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Jordi Riera Heredia

Institutions of which they are part

Research technician
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

I'm Jordi Riera Heredia, Laboratory technician, currently working in the Neurodegenerative group. I have been a technician since 2008. I have been a technician in different institutions.

-2018-Actualitat Laboratory Technician. Group malàlties Neurodegeneratives
-2016-2018 Laboratory Technician. Empresa privada
-2011-2016 Laboratory Technician. Institut de recerca Idibell
-2009-2011 Laboratory Technician. UB Barcelona departament Microbiólogia
-2008-2009 Aux. Laboratory Technician. Catlab

Projects

Caracterització genètica i desenvolupament de noves estratègies traslacionals en la malatia de Parkinson

IP: Marta Martínez Vicente
Collaborators: Jordi Riera Heredia, Laia Perez Lasarte
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 67280.97
Reference: SLT006/17/00268
Duration: 12/03/2018 - 31/12/2020

La disfunción autofágica/lisosomal en la enfermedad de Parkinson: caracterización y desarrollo de nuevas estrategias traslacionales con el lisosoma como diana terapéutica

IP: Marta Martínez Vicente
Collaborators: Jorge Hernández Vara, Oriol de Fabregues-Boixar Nebot, Thais Cuadros Arasa, Jordi Riera Heredia, Marta Montpeyó Garcia-Moreno, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI17/00496
Duration: 01/01/2018 - 30/06/2021

Related news

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.